Stefan Barth
Overview
Explore the profile of Stefan Barth including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
1461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dogbey D, Barth S
Mol Biotechnol
. 2025 Jan;
PMID: 39881109
The field of gene therapy has witnessed significant advancements in the utilization of Adeno-associated virus (AAV) owing to its inherent biological advantages. Targeted AAV vectors are generated through genetic or...
2.
Mungra N, Nsole Biteghe F, Huysamen A, Hardcastle N, Bunjun R, Naran K, et al.
Mol Pharm
. 2024 Jul;
21(8):4098-4115.
PMID: 39047292
Triple-negative breast cancer (TNBC) is the deadliest form of breast cancer with limited treatment options. The persistence of highly tumorigenic CD44-expressing subpopulation referred to as cancer stem cells (CSCs), endowed...
3.
Carrera Espinoza R, Alvarez Vera M, Wettlaufer M, Kerl M, Barth S, Moreno Garibaldi P, et al.
Materials (Basel)
. 2024 Jul;
17(13).
PMID: 38998140
DIN 16MnCr5 is commonly used in mechanical engineering contact applications such as gears, joint parts, shafts, gear wheels, camshafts, bolts, pins, and cardan joints, among others. This study examined the...
4.
Ramamurthy D, Nundalall T, Cingo S, Mungra N, Karaan M, Naran K, et al.
Immunother Adv
. 2024 Apr;
1(1):ltaa007.
PMID: 38626281
Immunotherapies are disease management strategies that target or manipulate components of the immune system. Infectious diseases pose a significant threat to human health as evidenced by countries continuing to grapple...
5.
Picher E, Wahajuddin M, Barth S, Chisholm J, Shipley J, Pors K
Cancers (Basel)
. 2024 Mar;
16(5).
PMID: 38473371
Rhabdomyosarcoma (RMS) is a rare soft tissue sarcoma (STS) that predominantly affects children and teenagers. It is the most common STS in children (40%) and accounts for 5-8% of total...
6.
Sinkala M, Naran K, Ramamurthy D, Mungra N, Dzobo K, Martin D, et al.
PLoS One
. 2024 Feb;
19(2):e0296511.
PMID: 38306344
Breast cancer responds variably to anticancer therapies, often leading to significant off-target effects. This study proposes that the variability in tumour responses and drug-induced adverse events is linked to the...
7.
Jacobs R, Dogbey M, Mnyandu N, Neves K, Barth S, Arbuthnot P, et al.
Microorganisms
. 2023 Dec;
11(12).
PMID: 38138129
Hepatitis B virus (HBV) has afflicted humankind for decades and there is still no treatment that can clear the infection. The development of recombinant adeno-associated virus (rAAV)-based gene therapy for...
8.
Lu M, Xing H, Shao W, Wu P, Fan Y, He H, et al.
Acta Pharm Sin B
. 2023 Sep;
13(9):3945-3955.
PMID: 37719367
Immunotherapy has revolutionized the landscape of cancer treatment. However, single immunotherapy only works well in a small subset of patients. Combined immunotherapy with antitumor synergism holds considerable potential to boost...
9.
Mungra N, Biteghe F, Malindi Z, Huysamen A, Karaan M, Hardcastle N, et al.
J Cancer Res Clin Oncol
. 2023 Jul;
149(13):12203-12225.
PMID: 37432459
Purpose: Triple-negative breast cancer (TNBC) is phenotypic of breast tumors lacking expression of the estrogen receptor (ER), the progesterone receptor (PgR), and the human epidermal growth factor receptor 2 (HER2)....
10.
Dogbey D, Torres V, Fajemisin E, Mpondo L, Ngwenya T, Akinrinmade O, et al.
Drug Deliv Transl Res
. 2023 Jun;
13(11):2719-2738.
PMID: 37301780
The burden of cancer is increasing globally. Several challenges facing its mainstream treatment approaches have formed the basis for the development of targeted delivery systems to carry and distribute anti-cancer...